Erratum: Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis

Erratum: Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis

Saved in:

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Microbiology
Subjects:	pulmonary tuberculosis BCG vaccine adenovirus vector multi-antigenic vaccine immunization mouse model
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1605861/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis
by: Jin-Seung Yun, et al.
Published: (2025-01-01)

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice
by: Danang Fang, et al.
Published: (2024-12-01)

A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models
by: Lidia del Pozo-Ramos, et al.
Published: (2025-05-01)

Immunogenicity and Protective Efficacy of a Multi-Antigen <i>Mycobacterium tuberculosis</i> Subunit Vaccine in Mice
by: Annuurun Nisa, et al.
Published: (2024-08-01)

Comparative transcriptomic analysis of mouse macrophages infected with live attenuated vaccine strains of Mycobacterium tuberculosis
by: Raja Veerapandian, et al.
Published: (2025-07-01)

Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
by: Shengxue Luo, et al.
Published: (2021-01-01)

MDSC depletion during immunization with heat-killed Mycobacterium tuberculosis increases protection against BCG infection
by: Arpa Aintablian, et al.
Published: (2025-07-01)

Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings
by: Abebe Fromsa, et al.
Published: (2025-02-01)

Features of the development of tuberculosis in children not vaccinated with BCG
by: O. M. Raznatovska, et al.
Published: (2018-07-01)

Contemporary aspects of tuberculosis in children without BCG vaccination
by: M. N. Kondаkovа, et al.
Published: (2021-04-01)

Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01)

Corrigendum: Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2025-03-01)

Tuberculosis and COVID-19: Medical and Social Aspects
by: E. V. Savintseva, et al.
Published: (2022-04-01)

Inactivated mycobacterium paragordonae delivered via microneedle patches as a novel tuberculosis booster vaccine
by: Moonsu Lee, et al.
Published: (2025-12-01)

Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
by: E. P. Kharchenko
Published: (2020-11-01)

A temperature-responsive PLA-based nanosponge as a novel nanoadjuvant and efficient delivery carrier of Ag85B for effective vaccine against Mycobacterium tuberculosis
by: Jin-Seung Yun, et al.
Published: (2025-04-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: V. V. Yeremeev, et al.
Published: (2019-07-01)

Comparative immunogenicity of monovalent and bivalent adenovirus vaccines carrying spikes of early and late SARS-CoV-2 variants
by: Hengchun Li, et al.
Published: (2024-12-01)

Design of a multi-epitope vaccine against drug-resistant mycobacterium tuberculosis and mycobacterium bovis using reverse vaccinology
by: Eva Akurut, et al.
Published: (2025-07-01)

Development of a novel adenovirus type 4 vector as a promising respiratory vaccine vehicle
by: Jinghan Xu, et al.
Published: (2025-04-01)

Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis
by: Matteo Morandi, et al.
Published: (2013-03-01)

PRACTICE OF EARLY REDUCED-ANTIGENIC-LOAD BCG-M VACCINATION OF HIV-EXPOSED INFANTS
by: S. N. Shugaeva, et al.
Published: (2015-08-01)

Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigen induces partial protection in a mouse model
by: Alexa Dierig, et al.
Published: (2025-06-01)

Study of the immunological efficacy and safety of a candidate vaccine against Lassa hemorrhagic fever
by: O. Popova, et al.
Published: (2025-01-01)

BCG vaccination decline and pediatric tuberculosis rise in Brazil: spatial-temporal study
by: Fabiana Rabe Carvalho, et al.
Published: (2025-04-01)

Identification of immunogenic antigens and evaluation of vaccine candidates against Clostridium perfringens
by: Zewei Li, et al.
Published: (2024-12-01)

Enhanced construction of a bivalent adenovirus-based vaccine for preventing childhood pathogens: Human respiratory syncytial virus and norovirus
by: Ying-Chin Chen, et al.
Published: (2025-04-01)

Willingness to accept new TB vaccines among adults, adolescents and their caregivers in a high TB burden setting
by: K.N. Nelson, et al.
Published: (2025-07-01)

ON VACCINATION OF ADOLESCENTS AGAINST TUBERCULOSIS
by: L. A. Zazimko, et al.
Published: (2014-01-01)

Effects of Common Anti-Inflammatories on Adenovirus Entry and Their Physicochemical Properties: An In-Depth Study Using Cellular and Animal Models
by: Hector R. Galvan-Salazar, et al.
Published: (2024-08-01)

Comprehensive review of fowl and duck adenovirus vaccines development: innovations, challenges, and future directions
by: Mohammad Farzad AFSHAR, et al.
Published: (2025-06-01)

Evaluation of Immunogenicity of <i>Mycobacterium tuberculosis ag85ab</i> DNA Vaccine Delivered by Pulmonary Administration
by: Haimei Zhao, et al.
Published: (2025-04-01)

Local tuberculosis in children of the tender age
by: L. V. Poddubnaya, et al.
Published: (2016-06-01)

Effectiveness of the Bacillus Calmette-Guerin vaccine in an Indonesian population with D543N NRAMP1 polymorphism
by: Ikhwanuliman Putera, et al.
Published: (2015-01-01)

A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs
by: Yuan Zhang, et al.
Published: (2024-12-01)

Vaccination with a low dose of BCG or BCG∆BCG1419c protects against short-term Mycobacterium tuberculosis HN878 infection in male CB6F1 mice
by: Jorge Barrios-Payán, et al.
Published: (2025-07-01)

Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial
by: Jia-Wei Xu, et al.
Published: (2024-12-01)

Maternal and lactogenic immunity in gestating sows induced by adenoviruses expressing mucosal immunogens derived from porcine epidemic diarrhea virus
by: Namphueng Butkhot, et al.
Published: (2025-08-01)

The seroprevalence of adenoviruses since 20001
by: Lingling Hong, et al.
Published: (2025-12-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
by: Lwandile Bukula, et al.
Published: (2025-03-01)